Siritida Rabibhadana
Overview
Explore the profile of Siritida Rabibhadana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel D, Loffredo C, Pupacdi B, Rabibhadana S, Navasumrit P, Chaisaingmongkol J, et al.
Int J Cancer
. 2024 Dec;
PMID: 39653658
Glyphosate [N-(phosphonomethyl) glycine], a systemic herbicide, is used globally (825 million kg/year) in 750+ formulations. The International Agency for Research on Cancer classified glyphosate is a probable human carcinogen (Group...
2.
Pupacdi B, Loffredo C, Budhu A, Rabibhadana S, Bhudhisawasdi V, Pairojkul C, et al.
Int J Cancer
. 2024 May;
155(8):1387-1399.
PMID: 38761410
Thailand is among countries with the highest global incidence and mortality rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). While viral hepatitis and liver fluke infections have been associated...
3.
Kacar Z, Slud E, Levy D, Candia J, Budhu A, Forgues M, et al.
Commun Biol
. 2024 Mar;
7(1):383.
PMID: 38553628
Hepatocellular carcinoma (HCC) is a molecularly heterogeneous solid malignancy, and its fitness may be shaped by how its tumor cells evolve. However, ability to monitor tumor cell evolution is hampered...
4.
Do W, Wang L, Forgues M, Liu J, Rabibhadana S, Pupacdi B, et al.
Cell Rep Med
. 2023 Dec;
4(12):101328.
PMID: 38118412
This study evaluates the pan-serological profiles of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) compared to several diseased and non-diseased control populations to identify risk factors and biomarkers of liver...
5.
Pomyen Y, Chaisaingmongkol J, Rabibhadana S, Pupacdi B, Sripan D, Chornkrathok C, et al.
Sci Rep
. 2023 Jul;
13(1):11406.
PMID: 37452065
Primary liver cancer (PLC), which includes intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC), has the highest incidence of all cancer types in Thailand. Known etiological factors, such as viral hepatitis...
6.
Schaffer A, Dominguez D, Chapman L, Gertz E, Budhu A, Forgues M, et al.
BMC Genomics
. 2021 Nov;
22(1):814.
PMID: 34763675
Background: Engineered versions of adeno-associated virus (AAV) are commonly used in gene therapy but evidence revealing a potential oncogenic role of natural AAV in hepatocellular carcinoma (HCC) has raised concerns....
7.
Haznadar M, Diehl C, Parker A, Krausz K, Bowman E, Rabibhadana S, et al.
Cancer Epidemiol Biomarkers Prev
. 2019 Jul;
28(10):1704-1711.
PMID: 31358519
Background: Liver cancer is the second leading cause of cancer-related deaths worldwide. With a predicted 2.4-fold rise in liver cancer incidence by 2020, there is an urgent need for early,...
8.
Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon S, et al.
Cancer Cell
. 2017 Jun;
32(1):57-70.e3.
PMID: 28648284
Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We identified common molecular subtypes linked to similar prognosis among 199 Thai...
9.
Scarzello A, Jiang Q, Back T, Dang H, Hodge D, Hanson C, et al.
Gut
. 2015 Jul;
65(10):1765-75.
PMID: 26206664
Objectives: The relative contributions of inflammatory signalling and sequential oncogenic dysregulation driving liver cancer pathogenesis remain incompletely understood. Lymphotoxin-β receptor (LTβR) signalling is critically involved in hepatitis and liver tumorigenesis....